{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:49:05Z","timestamp":1773798545642,"version":"3.50.1"},"reference-count":46,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3245","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T22:21:47Z","timestamp":1425162107000},"page":"465-472","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosing Latent Tuberculosis in Immunocompromised Patients Measuring Blood IP-10 Production Capacity: An Analysis of Chronic Renal Failure Patients"],"prefix":"10.2169","volume":"54","author":[{"given":"Gulsah","family":"Gunluoglu","sequence":"first","affiliation":[{"name":"Department of Chest Diseases, Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem Cengiz","family":"Seyhan","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Medipol University Faculty of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumeyza","family":"Kazancioglu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Bezmialem Vakif University Faculty of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeki","family":"Gunluoglu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Faculty of Medicine, Medipol University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurdan Simsek","family":"Veske","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra Ertan","family":"Yazar","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Altin","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. WHO. Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. WHO, Geneva, Switzerland, 2005: 1-247."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Menzies D, Pai M, Comstock G. Meta-analysis: new tests in the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354, 2007.","DOI":"10.7326\/0003-4819-146-5-200703060-00006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104, 2000.","DOI":"10.1016\/S0140-6736(00)02742-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37: 88-99, 2011.","DOI":"10.1183\/09031936.00115110"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an up-date. Ann Intern Med 149: 177-184, 2008.","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ruhwald M, Dominguez J, Latorre I, et al; TBNET. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis 91: 260-267, 2011.","DOI":"10.1016\/j.tube.2011.01.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215, 2011.","DOI":"10.1038\/icb.2010.158"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chen J, Liu X. The role of interferon g in regulation of CD4+ T-cells and its clinical implications. Cell Immunol 254: 85-90, 2009.","DOI":"10.1016\/j.cellimm.2008.09.001"},{"key":"9","unstructured":"9. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61: 246-257, 1997."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ferrero E, Biswas P, Vettoretto K, et al. Macrophages exposed to Mycobacterium tuberculosisrelease chemokines able to re-cruit selected leukocytes subpopulations: focus on gammadelta cells. Immunology 108: 365-374, 2003.","DOI":"10.1046\/j.1365-2567.2003.01600.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 12: 175-187, 2012.","DOI":"10.1586\/erm.11.97"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128, 2001.","DOI":"10.1038\/84219"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. IP-10\/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812, 2007.","DOI":"10.1016\/j.micinf.2007.02.021"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kabeer BS, Sikhamani R, Raja A. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis 71: 236-243, 2011.","DOI":"10.1016\/j.diagmicrobio.2011.07.012"},{"key":"15","unstructured":"15. Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 13: 731-736, 2009."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better bio-marker for active and latent tuberculosis in children than IFN gamma? PLoS One 3: e3901, 2008.","DOI":"10.1371\/journal.pone.0003901"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 3: e2858, 2008.","DOI":"10.1371\/journal.pone.0002858"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dheda K, van Zyl Smit R, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200, 2009.","DOI":"10.1097\/MCP.0b013e32832a0adc"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Goletti D, Raja A, Syed Ahamed Kabeer B, et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 5: e12577, 2010.","DOI":"10.1371\/journal.pone.0012577"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Aabye MG, Ruhwald M, Praygod G. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 36: 1488-1490, 2010.","DOI":"10.1183\/09031936.00039010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB. Eur Respir J 32: 1607-1615, 2008.","DOI":"10.1183\/09031936.00055508"},{"key":"22","unstructured":"22. Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 34 (ACS-6): 1-13, 2008."},{"key":"23","unstructured":"23. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49: 1-51, 2000."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 93: 69-84, 2010.","DOI":"10.1093\/bmb\/ldp039"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Raby E, Moyo M, Devendra A, et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS ONE 3: e2489, 2008.","DOI":"10.1371\/journal.pone.0002489"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ruhwald M, Ravn P. Immune reconstitution syndrome in tuberculosis and HIV-co-infected patients: Th1 explosion or cytokine storm? AIDS 21: 882-884, 2007.","DOI":"10.1097\/QAD.0b013e3280b079c8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shankar MS, Aravindan AN, Sohal PM, et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 20: 2720-2724, 2005.","DOI":"10.1093\/ndt\/gfi141"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Abdelrahman M, Sinha AK, Karkar A. Tuberculosis in end-stage renal disease patients on hemodialysis. Hemodial Int 10: 360-364, 2006.","DOI":"10.1111\/j.1542-4758.2006.00130.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, and an expert physician panel. Clin J Am Soc Nephrol 2: 68-73, 2007.","DOI":"10.2215\/CJN.01280406"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet I. Assessment of an interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patients. Swiss Med Wkly 140: 286-292, 2010.","DOI":"10.4414\/smw.2010.12960"},{"key":"31","unstructured":"31. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49: 1-51, 2000."},{"key":"32","unstructured":"32. Cellestis. QuantiFERON s-TB Gold package insert. [Internet]. [cited 2013 Dec 20]. Available from: http:\/\/www.cellestis.com\/IRM\/content\/PI\/QFT\/2PK\/AU.pdf"},{"key":"33","unstructured":"33. RayBiotech. RayBio Human IP-10 ELISA Kit User Manual. [Internet]. [cited 2014 May 15]. Available from: http:\/\/www.raybiotech.com\/files\/manual\/ELISA\/ELH-IP10-001.pdf"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Azzurri A, Sow OY, Amedei A, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7: 1-8, 2005.","DOI":"10.1016\/j.micinf.2004.09.004"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10\/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812, 2007.","DOI":"10.1016\/j.micinf.2007.02.021"},{"key":"36","unstructured":"36. Turkish Ministry of Health Department of Tuberculosis Control. The Book of Tuberculosis Control in Turkey. Ankara, 2003: 10 (in Turkish)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 5: 1114-1122, 2010.","DOI":"10.2215\/CJN.09231209"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57: 804-809, 2002.","DOI":"10.1136\/thorax.57.9.804"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3: 103-110, 2006.","DOI":"10.1513\/pats.200511-119JH"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Richeldi L, Losi M, D'Amico R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136: 198-204, 2009.","DOI":"10.1378\/chest.08-2575"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Winthrop KL, Nyendak M, Calvet H, et al. Inter-feron-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 3: 1357-1363, 2008.","DOI":"10.2215\/CJN.01010208"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Seyhan EC, Sökücü S, Altin S, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 12: 98-105, 2010.","DOI":"10.1111\/j.1399-3062.2009.00469.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6: 413-422, 2006.","DOI":"10.1586\/14737159.6.3.413"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Frahm M, Goswami ND, Owzar K, et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis 91: 250-256, 2011.","DOI":"10.1016\/j.tube.2011.02.006"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Chakera A, Bennett SC, Cornall RJ. A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J Translat Med 9: 143, 2011.","DOI":"10.1186\/1479-5876-9-143"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Petrucci R, Abu Amer N, Gurgel RQ, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 27: 1073-1077, 2008.","DOI":"10.1097\/INF.0b013e31817d05a3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T14:32:15Z","timestamp":1691505135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/5\/54_54.3245\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3245","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}